Adefovir dipivoxil and Weakness - a phase IV clinical study of FDA data
Summary:
Weakness is found among people who take Adefovir dipivoxil, especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Adefovir dipivoxil and have Weakness. It is created by eHealthMe based on reports of 1,867 people who have side effects when taking Adefovir dipivoxil from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,867 people reported to have side effects when taking Adefovir dipivoxil.
Among them, 118 people (6.32%) have Weakness.
What is Adefovir dipivoxil?
Adefovir dipivoxil has active ingredients of adefovir dipivoxil. eHealthMe is studying from 1,868 Adefovir dipivoxil users for its effectiveness, alternative drugs and more.
What is Weakness?
Weakness is found to be associated with 5,211 drugs and 6,169 conditions by eHealthMe.
Number of Adefovir dipivoxil and Weakness reports submitted per year:
Time on Adefovir dipivoxil when people have Weakness *:
Gender of people who have Weakness when taking Adefovir dipivoxil*:
Age of people who have Weakness when taking Adefovir dipivoxil *:
Common drugs people take besides Adefovir dipivoxil *:
Common side effects people have besides Weakness *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Adefovir dipivoxil and have Weakness?
Check whether Weakness is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of adefovir dipivoxil:
Alternative drugs to, pros and cons of Adefovir dipivoxil:
- Adefovir dipivoxil (1,868 reports)
Common Adefovir dipivoxil side effects:
- Osteomalacia (softening of the bones due to a lack of vitamin d): 247 reports
- Osteoporosis (bones weak and more likely to break): 166 reports
- Drug ineffective: 164 reports
- Weakness: 118 reports
Browse all side effects of Adefovir dipivoxil:
a b c d e f g h i j k l m n o p q r s t u v w x y zWeakness treatments and more:
- Weakness (513,300 reports)
COVID vaccines that are related to Weakness:
- Weakness in Moderna COVID Vaccine
- Weakness in Pfizer BioNTech Covid Vaccine
- Weakness in Johnson and Johnson Covid Vaccine
Common drugs associated with Weakness:
- Prednisone: 26,970 reports
- Aspirin: 26,881 reports
- Humira: 16,920 reports
- Methotrexate: 16,130 reports
- Metformin: 15,821 reports
- Omeprazole: 15,424 reports
- Tysabri: 14,800 reports
- Lisinopril: 14,469 reports
- Lipitor: 14,239 reports
- Synthroid: 13,523 reports
All the drugs that are associated with Weakness:
- Weakness (5,211 drugs)
Common conditions associated with Weakness:
- Multiple sclerosis: 44,040 reports
- High blood pressure: 24,528 reports
- Rheumatoid arthritis: 22,768 reports
- High blood cholesterol: 17,735 reports
- Pain: 15,184 reports
- Osteoporosis: 13,578 reports
- Multiple myeloma: 13,527 reports
All the conditions that are associated with Weakness:
- Weakness (6,169 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on adefovir dipivoxil (the active ingredients of Adefovir dipivoxil) and Adefovir dipivoxil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vasotec and Pupillary Reflex Impaired - a second ago
- Octreotide Acetate and Xeloda drug interaction - 6 seconds ago
- Clonidine and Euphoric Mood - 9 seconds ago
- Synthroid and Erythema Multiforme - 27 seconds ago
- Aciphex and Weakness - 28 seconds ago
- Iron Deficiency Anaemia and Vision Blurred - 36 seconds ago
- Actos and Weakness - 42 seconds ago
- Trileptal and Postural Orthostatic Tachycardia Syndrome - 46 seconds ago
- Veletri and Hydroxyzine Hydrochloride drug interaction - 46 seconds ago
- Weight Loss and Major Depression - a minute ago